Condition

Recurrent Adamantinomatous Craniopharyngioma clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Treatment of pediatric adamantinomatous craniopharyngioma with MEKTOVI

  This study is testing if a new drug called MEKTOVI can help young patients with a tough brain tumor called adamantinomatous craniopharyngioma feel better and manage their condition.

  Recruiting at 10 sites Phase 2 Nationwide Children's Hospital · Aurora, Colorado and 9 other locations · NCT05286788

• Using ACTEMRA to treat pediatric brain tumors

  This study is testing if the drug ACTEMRA can help children and young adults with a specific type of brain tumor feel better and improve their quality of life.

  Recruiting at 13 sites Phase 2 Nationwide Children's Hospital · Aurora, Colorado and 13 other locations · NCT05233397

Related topics

Quick answers

How many Recurrent Adamantinomatous Craniopharyngioma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Australia (2 trials), Canada (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →